Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, October 17, 2022
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
[ Mon, Oct 17th 2022
] - WOPRAI
Ed Arce Maintained (TVTX) at Strong Buy with Decreased Target to $36 on, Oct 17th, 2022
Ed Arce of HC Wainwright & Co., Maintained "Travere Therapeutics, Inc." (TVTX) at Strong Buy with Decreased Target from $42 to $36 on, Oct 17th, 2022.
Ed has made no other calls on TVTX in the last 4 months.
There are 3 other peers that have a rating on TVTX. Out of the 3 peers that are also analyzing TVTX, 0 agree with Ed's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Ed
- Do Kim of "Piper Sandler" Maintained at Buy with Decreased Target to $38 on, Friday, October 14th, 2022
- Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $45 on, Friday, August 5th, 2022
- Edward Nash of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $42 on, Thursday, July 14th, 2022
